Tariffs should not influence decisions at Indian drug companies, Cipla's top executive said on Friday, as the industry braces ...

Cipla has launched an innovative combination of 3 HIV/AIDS drugs, Viraday that needs to be taken just once a day for effective treatment. Cipla has launched an innovative combination of 3 HIV/AIDS ...

NEW DELHI: Indian Pharmaceutical company Cipla has offered to manufacture an ... particular drug than the individual effect of both the drugs combined. India To Procure 1 Million Doses Of Tamiflu ...

The adjustment follows Cipla's third-quarter results ... postponement of the launches of gAbraxane and gAdvair, two generic drugs, which are now anticipated to enter the market in the second ...

New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

The Indian Pharmaceutical Alliance (IPA) has proposed reducing the import duty on pharma products from the US to zero.

Indian pharmaceutical industry leaders indicate that proposed US tariffs on pharmaceutical exports may lead to increased drug ...

The pharma sector export data for fourth quarter has been released. According to Phillip Capital, the latest export data ...

While stocks such as Sun Pharma, Lupin, Cipla, Alkem Labs, Torrent Pharma and Cadila Healthcare ... The revised prices would be printed on the new batches of packing of the impacted drugs.

MUMBAI/BENGALURU, Feb 28 (Reuters) - Tariffs should not influence decisions at Indian drug companies, Cipla's (CIPL.NS ... for cheaper versions of popular drugs. "I'm not sure tariffs should ...